Search

everythinglearnresearchcommunity

for

Search:↓

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Sebocytes play a key role in controlling androgen levels in human skin.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Keratin 17 is crucial for normal hair growth by regulating hair cycle transitions with TNFα.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Nonclassic 21-hydroxylase deficiency is a common, treatable genetic disorder causing reversible symptoms like acne and hair loss.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Acne not improved by usual treatments may indicate a genetic disorder.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Injecting specific oligonucleotides can change hair growth and structure by altering a gene.

Cortisone reductase deficiency can cause high androgen and cortisol levels and may be missed in women with similar symptoms.